用于治疗高血压的新一代二氢吡啶类药物。
New generations of dihydropyridines for treatment of hypertension.
作者信息
Wang Angela L, Iadecola Costantino, Wang Gang
机构信息
Premed Program, Washington University in St. Louis, St. Louis, MO, USA.
Feil Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, USA.
出版信息
J Geriatr Cardiol. 2017 Jan;14(1):67-72. doi: 10.11909/j.issn.1671-5411.2017.01.006.
Abstract
Since the calcium channel blocker (CCB) has become one of the most prescribed agents for antihypertensive monotherapy in the world, this brief review will focus on the recent research and development of the dihydropyridine (DHP) CCB, addressing pharmacological mechanisms for the clinical efficacy of the third and fourth generations of the DHP CCBs, especially on their possible central mechanisms underlying lowering blood pressure.
摘要
由于钙通道阻滞剂（CCB）已成为全球最常用于抗高血压单一疗法的药物之一，本简要综述将聚焦于二氢吡啶（DHP）CCB的最新研究与开发，阐述第三代和第四代DHP CCB临床疗效的药理学机制，尤其是其降低血压的潜在中枢机制。
相似文献
1
New generations of dihydropyridines for treatment of hypertension.用于治疗高血压的新一代二氢吡啶类药物。
J Geriatr Cardiol. 2017 Jan;14(1):67-72. doi: 10.11909/j.issn.1671-5411.2017.01.006.
2
Efficacy and safety of dual calcium channel blockade for the treatment of hypertension: a meta-analysis.双重钙通道阻滞剂治疗高血压的疗效和安全性：荟萃分析。
Am J Hypertens. 2013 Feb;26(2):287-97. doi: 10.1093/ajh/hps009. Epub 2012 Dec 13.
3
Lercanidipine: a novel dihydropyridine calcium-channel blocker.乐卡地平：一种新型二氢吡啶类钙通道阻滞剂。
Heart Dis. 2001 Nov-Dec;3(6):398-407. doi: 10.1097/00132580-200111000-00008.
4
Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.钙通道阻滞剂引起的下肢水肿用袢利尿剂治疗的程度和特征。
JAMA Netw Open. 2019 Dec 2;2(12):e1918425. doi: 10.1001/jamanetworkopen.2019.18425.
5
Dual calcium-channel blocker therapy in the treatment of hypertension.双重钙通道阻滞剂疗法治疗高血压
Ann Pharmacother. 1996 Jul-Aug;30(7-8):802-10. doi: 10.1177/106002809603000719.
6
Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy.血管紧张素受体阻滞剂与二氢吡啶类钙通道阻滞剂联合用药：高血压治疗中的一种新兴策略。
Postgrad Med. 2009 Mar;121(2):25-39. doi: 10.3810/pgm.2009.03.1974.
7
[24-hour perfect BP-lowering therapy using long-acting dihydropyridine calcium channel blockers].使用长效二氢吡啶类钙通道阻滞剂的24小时完美降压疗法
Nihon Rinsho. 2014 Aug;72(8):1461-5.
8
9
Dihydropyridine calcium channel blockers: basic pharmacological similarities but fundamental therapeutic differences.二氢吡啶类钙通道阻滞剂：基本药理相似性但存在根本治疗差异。
J Hypertens. 2004 Sep;22(9):1641-8. doi: 10.1097/00004872-200409000-00002.
10
Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.一项比较乐卡地平与其他二氢吡啶类钙通道阻滞剂耐受性的荟萃分析结果。
Clin Ther. 2009 Aug;31(8):1652-63. doi: 10.1016/j.clinthera.2009.08.010.
引用本文的文献
1
Stem Cell Therapy Approaches for Ischemia: Assessing Current Innovations and Future Directions.用于缺血的干细胞治疗方法：评估当前创新与未来方向
Int J Mol Sci. 2025 Jun 30;26(13):6320. doi: 10.3390/ijms26136320.
2
Adverse events associated with amlodipine: a pharmacovigilance study using the FDA adverse event reporting system.与氨氯地平相关的不良事件：一项使用美国食品药品监督管理局不良事件报告系统的药物警戒研究。
Front Cardiovasc Med. 2025 May 6;12:1504671. doi: 10.3389/fcvm.2025.1504671. eCollection 2025.
3
Updates on Intrinsic Medicinal Chemistry of 1,4-dihydropyridines, Perspectives on Synthesis and Pharmacokinetics of Novel 1,4-dihydropyrimidines as Calcium Channel Blockers: Clinical Pharmacology.1,4 - 二氢吡啶的内在药物化学进展，新型1,4 - 二氢嘧啶作为钙通道阻滞剂的合成与药代动力学展望：临床药理学
Curr Top Med Chem. 2025 Jan 1. doi: 10.2174/0115680266323908241114064318.
4
Discovery of New Symmetrical and Asymmetrical 1,4-dihydropyridine Derivatives as Potential Antihypertensive Agents: An Evaluation.新型对称和不对称1,4 - 二氢吡啶衍生物作为潜在抗高血压药物的发现：一项评估。
Curr Hypertens Rev. 2025;21(1):45-61. doi: 10.2174/0115734021328359241206073629.
5
Design, Screening, Synthesis, Characterisation and DFT-based Electronic Properties of Dihydropyridine-based Molecule as L-type Calcium Channel Blocker.基于二氢吡啶的 L 型钙通道阻滞剂分子的设计、筛选、合成、表征及基于密度泛函理论的电子性质研究。
Curr Comput Aided Drug Des. 2024;20(7):1130-1146. doi: 10.2174/0115734099273719231005062524.
6
Death due to unrecognized intoxication of nifedipine in an adult.一名成年人因未被识别的硝苯地平中毒死亡。
Forensic Toxicol. 2025 Jan;43(1):172-175. doi: 10.1007/s11419-024-00704-1. Epub 2024 Sep 23.
7
Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems.在实验系统中增加淀粉样蛋白-β脑外排的方法。
J Alzheimers Dis. 2024;100(2):379-411. doi: 10.3233/JAD-240212.
8
Mechanisms of dihydropyridine agonists and antagonists in view of cryo-EM structures of calcium and sodium channels.二氢吡啶激动剂和拮抗剂作用机制的冷冻电镜结构研究：钙通道和钠通道。
J Gen Physiol. 2023 Nov 6;155(11). doi: 10.1085/jgp.202313418. Epub 2023 Sep 20.
9
Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Pyrimidine Derivatives as Potential Calcium Channel Blockers.设计、合成、分子模拟及新型嘧啶衍生物作为潜在钙通道阻滞剂的生物学评价。
Molecules. 2023 Jun 20;28(12):4869. doi: 10.3390/molecules28124869.
10
Therapeutic Usefulness of a Novel Calcium Channel Blocker Azelnidipine in the Treatment of Hypertension: A Narrative Review.新型钙通道阻滞剂阿折地平在高血压治疗中的治疗效用：一项叙述性综述
Cardiol Ther. 2022 Dec;11(4):473-489. doi: 10.1007/s40119-022-00276-4. Epub 2022 Aug 13.
本文引用的文献
1
A review on prescribing patterns of antihypertensive drugs.抗高血压药物处方模式综述。
Clin Hypertens. 2016 Mar 27;22:7. doi: 10.1186/s40885-016-0042-0. eCollection 2015.
2
Cilnidipine but not amlodipine suppresses sympathetic activation elicited by isometric exercise in hypertensive patients.西尼地平能抑制高血压患者等长运动引起的交感神经兴奋，氨氯地平则没有这种作用。
Clin Exp Hypertens. 2015;37(7):531-5. doi: 10.3109/10641963.2015.1025959. Epub 2015 May 15.
3
Comparison of amlodipine with cilnidipine on antihypertensive efficacy and incidence of pedal edema in mild to moderate hypertensive individuals: A prospective study.氨氯地平与西尼地平对轻至中度高血压患者降压疗效及足踝部水肿发生率的比较：一项前瞻性研究。
J Adv Pharm Technol Res. 2015 Apr-Jun;6(2):81-5. doi: 10.4103/2231-4040.154543.
4
Long-term safety and efficacy of high-dose controlled-release nifedipine (80 mg per day) in Japanese patients with essential hypertension.大剂量控释硝苯地平（每日80毫克）对日本原发性高血压患者的长期安全性及疗效
Hypertens Res. 2015 Oct;38(10):695-700. doi: 10.1038/hr.2015.54. Epub 2015 Apr 16.
5
Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: association with BNP and aldosterone levels.西尼地平对2型糖尿病高血压患者交感神经活性及心肾功能的影响：与脑钠肽和醛固酮水平的关系
Diabetes Res Clin Pract. 2014 Dec;106(3):504-10. doi: 10.1016/j.diabres.2014.09.056. Epub 2014 Oct 25.
6
JNC8 guidelines for the management of hypertension in adults.美国成人高血压管理的第8版联合国家委员会（JNC8）指南
Am Fam Physician. 2014 Oct 1;90(7):503-4.
7
Clinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoring.2013年欧洲高血压学会/欧洲心脏病学会高血压指南的临床意义：治疗目标、治疗选择及血压监测
Drugs R D. 2014 Jun;14(2):31-43. doi: 10.1007/s40268-014-0049-5.
8
Neuronal voltage-gated calcium channels: structure, function, and dysfunction.神经元电压门控钙通道：结构、功能与功能障碍。
Neuron. 2014 Apr 2;82(1):24-45. doi: 10.1016/j.neuron.2014.03.016.
9
Antihypertensive effect of barnidipine 10 mg or amlodipine 5 to 10 mg once daily in treatment-naive patients with essential hypertension: A 24-week, randomized, open-label, pilot study.在初治原发性高血压患者中，每日一次服用10毫克巴尼地平或5至10毫克氨氯地平的降压效果：一项为期24周的随机、开放标签的试点研究。
Curr Ther Res Clin Exp. 2008 Jun;69(3):192-206. doi: 10.1016/j.curtheres.2008.06.002.
10
The fourth-generation Calcium channel blocker: cilnidipine.第四代钙通道阻滞剂：西尼地平。
Indian Heart J. 2013 Dec;65(6):691-5. doi: 10.1016/j.ihj.2013.11.001.
Zotero 插件